First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT06217822 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Metastatic Castration-resistant Prostate Cancer
Prostate Specific Membrane Antigen (PSMA) Expression

Interventions

DRUG: 225Ac-PSMA-Trillium (BAY3563254)

Sponsor

Bayer